| Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression M Moccia, R Lanzillo, R Palladino, KCM Chang, T Costabile, C Russo, ... Multiple Sclerosis Journal 22 (5), 659-667, 2016 | 86 | 2016 |
| Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis R Lanzillo, G Cennamo, C Criscuolo, A Carotenuto, N Velotti, F Sparnelli, ... Multiple Sclerosis Journal 24 (13), 1706-1714, 2018 | 60 | 2018 |
| The Framingham cardiovascular risk score in multiple sclerosis M Moccia, R Lanzillo, R Palladino, GT Maniscalco, A De Rosa, C Russo, ... European journal of neurology 22 (8), 1176-1183, 2015 | 51 | 2015 |
| Quality of life and cognitive functions in early onset multiple sclerosis R Lanzillo, A Chiodi, A Carotenuto, V Magri, A Napolitano, R Liuzzi, ... european journal of paediatric neurology 20 (1), 158-163, 2016 | 39 | 2016 |
| The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests F Saccà, T Costabile, A Carotenuto, R Lanzillo, M Moccia, C Pane, ... Multiple Sclerosis Journal 23 (9), 1289-1296, 2017 | 36 | 2017 |
| Communication in multiple sclerosis: pragmatic deficit and its relation with cognition and social cognition A Carotenuto, G Arcara, G Orefice, I Cerillo, V Giannino, M Rasulo, ... Archives of Clinical Neuropsychology 33 (2), 194-205, 2018 | 34 | 2018 |
| Oral palmitoylethanolamide treatment is associated with reduced cutaneous adverse effects of interferon-β1a and circulating proinflammatory cytokines in relapsing–remitting … NS Orefice, M Alhouayek, A Carotenuto, S Montella, F Barbato, A Comelli, ... Neurotherapeutics 13 (2), 428-438, 2016 | 33 | 2016 |
| Electroencephalographic features in Dravet syndrome: five-year follow-up study in 22 patients N Specchio, M Balestri, M Trivisano, N Japaridze, P Striano, A Carotenuto, ... Journal of child neurology 27 (4), 439-444, 2012 | 33 | 2012 |
| Uric acid: a potential biomarker of multiple sclerosis and of its disability M Moccia, R Lanzillo, R Palladino, C Russo, A Carotenuto, M Massarelli, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (5), 753-759, 2015 | 32 | 2015 |
| Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study M Moccia, R Lanzillo, T Costabile, C Russo, A Carotenuto, G Sasso, ... Journal of neurology 262 (4), 961-967, 2015 | 27 | 2015 |
| Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study M Moccia, R Lanzillo, T Costabile, C Russo, A Carotenuto, G Sasso, ... Journal of neurology 262 (4), 961-967, 2015 | 27 | 2015 |
| Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis M Moccia, A Capacchione, R Lanzillo, F Carbone, T Micillo, F Perna, ... Therapeutic advances in neurological disorders 12, 1756286418819074, 2019 | 24 | 2019 |
| Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy R Iodice, A Carotenuto, R Dubbioso, I Cerillo, L Santoro, F Manganelli Journal of the neurological sciences 365, 143-146, 2016 | 24 | 2016 |
| CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients A Carotenuto, G Scalia, F Ausiello, M Moccia, CV Russo, F Saccà, ... Journal of neuroimmunology 309, 47-50, 2017 | 22 | 2017 |
| Anatomical and functional retinal changes in multiple sclerosis G Cennamo, MR Romano, EC Vecchio, C Minervino, C Della Guardia, ... Eye 30 (3), 456-462, 2016 | 22 | 2016 |
| Can people with multiple sclerosis actually understand what they read in the Internet age? M Moccia, A Carotenuto, M Massarelli, R Lanzillo, VB Morra Journal of Clinical Neuroscience 25, 167-168, 2016 | 22 | 2016 |
| Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice R Lanzillo, S Bonavita, M Quarantelli, G Vacca, G Lus, L Amato, ... Neurological Sciences 34 (4), 521-528, 2013 | 22 | 2013 |
| A longitudinal real‐life comparison study of natalizumab and fingolimod R Lanzillo, A Carotenuto, M Moccia, F Saccà, CV Russo, M Massarelli, ... Acta Neurologica Scandinavica 136 (3), 217-222, 2017 | 19 | 2017 |
| No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing–remitting multiple sclerosis (the ARIANNA study) R Lanzillo, M Quarantelli, C Pozzilli, M Trojano, MP Amato, MG Marrosu, ... Multiple Sclerosis Journal 22 (9), 1163-1173, 2016 | 19 | 2016 |
| Epilepsy in ring 14 chromosome syndrome N Specchio, M Trivisano, D Serino, S Cappelletti, A Carotenuto, D Claps, ... Epilepsy & Behavior 25 (4), 585-592, 2012 | 18 | 2012 |
